Lithium Americas

Phase A — Understand the business

Lens 1 · Company Overview

LAC is a British Columbia-domiciled resource company (NYSE/TSX: LAC), spun out of Old LAC (now Lithium Argentina) in the October 2023 Separation. Its sole material asset is Thacker Pass in the McDermitt Caldera, Humboldt County, Nevada — described in the filing as "the largest lithium Measured and Indicated Resource in the world".

Business model: dig clay, leach lithium with on-site sulfuric acid, crystallize battery-grade lithium carbonate (Li₂CO₃), sell it under long-dated offtake. There is no recurring revenue today — the model is "build a mine, then sell a commodity."

Ownership of the asset (this is the crux and unusually complex for a $1.7bn company):

• Thacker Pass is held by Lithium Nevada LLC (LN), under the JV Lithium Nevada Ventures LLC — 62% LAC / 38% GM. LAC consolidates the JV (it is the primary beneficiary of a VIE) and manages the project.
• The US DOE holds warrants (issued 30 Jan 2026) that, if exercised, give it 5% of LAC equity (18.3m shares at $0.01) and a 5% economic (non-voting) JV interest — post-exercise the JV economics become 59% LAC / 36% GM / 5% DOE, voting still 62/38.

Key products: battery-grade lithium carbonate. Phase 1 targets 40,000 t/y; the five-phase plan targets 160,000 t/y over an 85-year mine life.

Key customer: General Motors — 20-year Phase 1 offtake for up to 100% of Phase 1 volume (GM must buy ≥20% of its own lithium needs from Phase 1), plus a 20-year Phase 2 offtake for up to 38% of Phase 2. This is single-customer concentration by design.

Key contractor: Bechtel (EPCM, cost-reimbursable). Sawtooth Mining (NACCO subsidiary) does the actual mining under a mine-services agreement.

Payment terms / contract structure: offtake pricing is "based on an agreed upon price formula linked to prevailing market prices" — i.e. NOT a fixed take-or-pay floor; LAC still carries lithium-price risk. Management concluded no part of GM's investment was attributable to the offtake (it is market-priced), which is a notable accounting judgment (Lens 10).

Also holds minority investments in Green Technology Metals (GT1) and Ascend Elements — the latter written down to $nil in Q1 2026 (see Lens 10).

Lens 2 · Supply Chain

Upstream (inputs LAC must buy for the process plant) → LAC → end customer. Named stakeholders along the chain:

Reagents (the operating supply chain — not yet contracted; LAC is "currently working on securing suppliers"): sulfur (→ sulfuric acid for leaching), limestone, quicklime, soda ash (sodium carbonate from trona — the second-largest reagent cost driver), caustic soda, flocculant, CO₂, ferric sulfate, hydrochloric acid. Chokepoint: soda ash and liquid sulfur are the bulk reagents; LAC's stated goal is to source "the majority of reagents from continental North America" to cut carbon + transport cost, delivered via the planned Transload Terminal (TLT) operated by Iron Horse Terminals (rail 60 miles away in Winnemucca).

Construction supply chain (the live chokepoint today):

• Structural steel sourced from the UAE — >75% in transit/on-site as of Q1 2026, and the filing explicitly flags Strait of Hormuz / Middle East conflict risk, with steel re-routed through the Port of Jeddah. This is a real, named single-source geographic dependency.
• Key vendors: Bechtel (EPCM), Aquatech (purification/crystallization), MECS/Elessent (sulfuric-acid plant IP license), M3 / ITAC / EXP / EDG (engineering), Target Hospitality (workforce housing).
• Tariff exposure on imported equipment/materials (Canada, China, India, UAE, Turkey, EU): estimated $80–120m on Phase 1, most incurred in 2026 — explicitly excluded from the $2.93bn capex estimate.

Power: Harney Electric Cooperative + 35 MW of Bonneville hydropower; six regional substations upgraded (completed ahead of schedule, Mar 2026).

Downstream: Li₂CO₃ → GM (batteries) + third-party offtakers permitted for uncommitted first-five-year volumes. Single-buyer concentration is the defining downstream feature.

Names or it didn't happen — delivered. The one gap: reagent suppliers are genuinely not yet locked, which is normal at this construction stage but is a forward execution item.

Lens 3 · Competitive Advantages (moats)

LAC's moat is not product differentiation — battery-grade Li₂CO₃ is a commodity graded to spec. The moats are structural and mostly not yet proven:

1. Resource scale + location (real, durable). Largest lithium M&I resource in the world, on US soil, on BLM land with all Phase 1–2 permits in hand and litigation resolved (Lens 10). In a world where the US wants to on-shore critical minerals, a permitted, at-scale, domestic deposit is genuinely scarce. 85-year mine life. This is the durable part.
2. The financing + sponsor stack (real, and the strongest moat). A $2.26bn (now $2.23bn) DOE loan at Treasury flat + 0% spread, 23-year tenor, no principal until Jan 2029 — this is below-market sovereign-adjacent debt no competitor can replicate. Plus GM as 38% partner + 20-year anchor offtake, plus Orion ($250m). The capital structure is the moat: it lets LAC build a $2.93bn Phase 1 (and eventually a $12.4bn five-phase plan) that no independent junior could finance.
3. Process IP (unproven). US Patent 12,188,107 B2 + pending applications on clay-leach and Mg/Li separation. But — the flowsheet has "not been demonstrated at commercial scale," which the company itself lists as a principal risk. So the "process moat" is a hypothesis until 2028.

Bargaining power: weak-to-neutral today. LAC needs GM (offtake + capital) and DOE (capital) more than they need LAC — evidenced by GM's ability to extract offtake priority + a "profit true-up," and DOE taking warrants + board observer rights. Against reagent suppliers LAC is a price-taker on soda ash/sulfur. Bargaining power only inverts if Thacker Pass becomes a scarce, low-cost, in-production US source — a 2028+ proposition. (Commercial-layer files — bottlenecks.md / positioning.md — are absent for critical-materials, so this lens leans on the filing + web.)

Lens 4 · Segments

One segment, one geography — the company states it "accounts for the business in one segment and one geographical area". segments.csv is empty because there is nothing to segment: no product revenue exists.

The only meaningful "segmentation" is by construction phase and by capital deployed:

• Capex cumulative to 31 Mar 2026: $1,277.2m, of which $1,138.1m counts against the $2.93bn Phase 1 estimate.
• Phase 1 is ~39% of the $2.93bn spent (as of Q1 2026), engineering >95% complete, procurement >70%.
• Net book value of the Thacker Pass property: $1,328.6m (10-K) → PP&E net $1,667.3m at Q1 2026.

Trend: capital deployment is accelerating (investing cash outflow $765m FY25 vs $178m FY24; $299m in Q1 2026 alone) — the physical build is on its steepest ramp.

---

Phase B — Measure performance

Framing note (honest re-point): LAC has no revenue, no consensus EPS to beat, and no operating peers to P/E-compare. Running Lenses 5 and 7 literally would fabricate meaning. Instead: Lens 5 assesses the latest print as a construction/liquidity scorecard; Lens 7 becomes a NAV / project-economics comp (the only defensible valuation frame for a builder). Every number labeled.

Lens 5 · "Earnings" Result → Construction & Liquidity Scorecard (Q1 2026, filed 14 May 2026)

There is no revenue to analyze. What the print actually tells you:

• Net income Q1 2026: +$4.6m (vs −$11.5m Q1 2025) — but this is entirely non-cash fair-value noise: a +$14.3m gain on the Orion convertible embedded derivative (because the share price fell $4.36→$3.95, shrinking the conversion liability). Net loss attributable to common stockholders was −$0.4m (−$0.00/sh). The "profit beat" headlines (breakeven vs a −$0.07 expected loss ) are an accounting artifact, not operating progress.
• Real operating burn: G&A $11.1m (up from $6.5m — hiring + SBC + community spend); operating cash burn −$18.3m for the quarter.
• The number that matters — liquidity: $1,207.6m total cash + restricted cash at 31 Mar 2026 ($758.5m cash + $449.1m restricted at the JV/LN level). Against a remaining ~$1.65bn to finish Phase 1 ($2.93bn − ~$1.28bn spent), plus the undrawn DOE balance (only $867m of $1.97bn principal drawn: $435m Oct 2025 + $432m Feb 2026).
• Balance-sheet flags: DOE Loan liability $702.9m and growing; convertible principal $113.2m (down from $195m via Orion conversions); JV warrant obligation $144.9m; total liabilities $1,235.8m. Ascend Elements investment written to $nil (−$4.5m in the quarter) — a small but telling read-through on the battery-recycling adjacency.
• Guidance / tone: FY2026 capex guidance $1.3–1.6bn reaffirmed; mechanical completion late 2027, ramp 2028 — unchanged. Management is now running a "definitive capital estimate" (targeting H2 2026) that will fold in tariffs, Middle East logistics, fuel and inflation "not included in the $2.93bn estimate". This is the single most important forward flag: the $2.93bn number is under review and the direction of the revision is up.
• Market reaction: stock is down ~13% YTD 2026, ~$4.84 in early July. The market is not rewarding construction milestones; it is discounting execution + dilution + a likely capex revision.

Verdict on the print: on schedule physically (eng >95%, steel arriving, first cable pulls done), fully funded for ~12 months, but the P&L is meaningless and the coming capex re-estimate is an overhang.

Lens 6 · Earnings Calls (sentiment trend)

No traditional earnings calls with revenue Q&A; management communicates via quarterly results + project-update pressers. Sentiment read from disclosure language + CEO commentary:

• Consistent, milestone-driven tone. CEO Jonathan Evans: construction "accelerating toward mechanical completion in late 2027," 1,300+ workers on site mid-May, 2,000+ at peak.
• What they keep repeating: "fully funded for Phase 1," "de-risking," permit certainty, safety (2.43m workhours, zero lost-time).
• What newly entered the language (the tell): explicit acknowledgment of tariff exposure ($80–120m), Strait of Hormuz steel-logistics risk, and a "definitive capital estimate" to capture cost inflation "not in the $2.93bn." The narrative has shifted from "de-risked and funded" (2025) toward "funded but managing new cost pressures" (2026) — a subtle but real softening. The DOE deferring $184m of debt service + injecting warrants (Oct 2025) reads as a positive government-backstop signal the market rewarded (+20–30% single session).

Lens 7 · Comps → NAV / project-economics frame (a P/E comp is n/a for a pre-revenue builder)

A conventional EV/EBITDA · P/E peer table is not meaningful and is not fabricated here. LAC has no EBITDA and negative EPS; forcing a multiple would be a hallucination. The honest comp is (a) how peers are priced given the sector's own earnings collapse, and (b) LAC's own NAV.

Read: the sector's multiples are garbage right now — ALB and PLS show 80–100x EV/EBITDA purely because 2025 lithium prices crushed EBITDA toward zero, not because they're expensive. This is itself the point: you cannot value LAC — or its peers — off current multiples; you value the reserve/NAV through the cycle.

NAV anchors (the defensible frame):

• Company technical-report economics (S-K 1300, at $24,000/t Li₂CO₃, 8% discount): Base Case (85-yr) after-tax NPV $8.7bn / IRR 20.0%; Production Scenario (Yrs 1–25) after-tax NPV $5.9bn / IRR 19.6%; payback 8.7 yrs. Sensitivity: at −25% price ($18k/t) NPV $3.4bn / IRR 12.8%; at +25% ($30k/t) NPV $13.6bn / IRR 26.5%. These are 100%-project, undiscounted-to-today, and pre-royalty/PPA — LAC owns 62% (59% post-DOE-warrant).
• Bearish third-party NAV: one analysis puts base NAV at ~$510m using far harsher inputs (40kt/y only, $9,500/t, 15% discount). The gulf between $8.7bn (company, $24k/t, 8%) and $0.5bn (bear, $9.5k/t, 15%) is the entire investment debate — it is almost entirely a lithium-price + discount-rate assumption, not a fact.
• Price-to-book: ~1.5x vs Canadian metals & mining ~3.3x — a book-value discount that reflects development risk, not cheapness per se.

At ~$4.84 / ~$1.7bn market cap, the market is capitalizing LAC's 62% stake at a deep discount to the company's own $24k/t NPV and a premium to the harshest bear NAV — i.e. pricing something like the $12–18k/t long-run band with meaningful execution haircut.

Lens 8 · Stock-Price Catalysts (last ~2 years — the moves that matter)

LAC's tape reacts to financing/government/permitting events far more than to lithium spot, because it has no revenue:

• Oct 2023 — Separation from Old LAC (LAC becomes a pure Thacker Pass play).
• Oct 2024 — DOE loan close ($2.26bn) + Dec 2024 GM JV close ($625m) — the de-risking events that made the project financeable.
• Apr 2025 — FID + Orion $250m — green light to major construction.
• Oct 2025 — DOE warrant/"government 5% stake" + first draw ($435m): shares +20–30% in a session — the market read it as Thacker Pass becoming a strategic national-security asset. This is the clearest single catalyst signature: government backing = the stock's biggest up-move.
• Jan–Jul 2026 — dilution + capex overhang: three ATM programs (68.2m shares in FY25 at avg $5.98; +32.5m in Q1 2026; a new $250m March 2026 ATM) + Orion conversions steadily grew the count to ~351m shares (from ~219m weighted a year earlier — a ~60% share-count increase). Stock −13% YTD. Goldman initiated Neutral, $4.50 (1 Jul 2026); NBC trimmed to C$7.25; consensus Hold, median ~$6.08–6.50.

What the pattern reveals: the market prices LAC as a policy-and-financing option, not a commodity play — DOE/GM news moves it up; dilution and cost-creep move it down; lithium spot is a distant third input until production. Lithium's 95% spot spike (Dec 2025 → Jan 2026, ~$13.4k → ~$26.3k/t ) helped sentiment but did not re-rate LAC the way the DOE stake did.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO — Jonathan (Jon) Evans (President & CEO since Aug 2019; joined as President/COO Sept 2018). Track record: ex-VP & GM of FMC Corp's Lithium Division (now Livent/Arcadium) — genuine, directly-relevant lithium-operations pedigree; prior roles at GE, Arysta LifeScience, AMRI, DiversiTech (Permira portco); US Army officer; Clarkson BSc (mech eng) + RPI MSc. This is a credible operator to build and run a chemical plant — arguably his single best qualification is that he actually ran a lithium chemicals business.
• Skin in the game: thin — Evans directly owns ~0.22% (~$4.36m). That's low insider ownership for a founder-scale bet; this is a professional-manager, not a founder-owner, situation. Detailed proxy insider data is incorporated by reference (2026 proxy not in the 10-K on the shelf), so insider-transactions.csv is absent — flagged as an open item.
• Capital-allocation history: LAC has, by any fair reading, executed an exceptional financing campaign — assembling DOE (below-market sovereign debt) + GM (strategic partner + offtake) + Orion into a fully-funded Phase 1, then topping up via ATMs "on an opportunistic basis as market conditions permit." The DOE-warrant amendment (deferring $184m debt service, adding $120m reserve) was a smart liquidity trade. The critique: heavy reliance on dilutive ATM issuance at $3.71–$8.19/share — ~60% more shares in a year — has been value-destructive per share even as it was survival-positive for the project. ROE/ROIC are negative/meaningless pre-production.
• Red flags (Lens 10 detail): none egregious. The related-party/insider structure is dominated by GM and DOE governance rights (board observer, put/call/exchange, offtake priority, profit true-up) — these are legitimate but they subordinate common holders' interests to two powerful counterparties.
• Archetype: professional operator + master financier, executing a national-strategic megaproject. The right archetype for this stage (financing + construction). The open question is whether the same team can hit a novel flowsheet's ramp curve — an operating skill not yet demonstrated here.

Lens 10 · Forensic Red Flags

Accounting-risk scan (development-stage, so the usual revenue-recognition/receivables/inventory vectors are largely N/A — there are no sales). The real forensic surface is capitalization, fair-value marks, and financing complexity:

1. Aggressive-looking (but defensible) capitalization. Everything is being capitalized into PP&E — including $29.7m FY25 / $13.7m Q1 2026 of finance costs (DOE + Orion interest) capitalized to Thacker Pass. This is standard for a qualifying asset under construction, but it means the income statement understates the true economic cost of capital and the balance-sheet asset ($1.67bn PP&E) is only as good as the eventual project economics. Impairment risk is the key forensic watch item — the 10-K's critical-estimate on Thacker Pass impairment hinges on "expected lithium prices" and the LOM plan; a sustained low-price environment could force a write-down.
2. Non-cash fair-value volatility dominates the P&L. FY25 showed a +$160m warrant gain and a −$171m convertible-debt loss that net to noise but swing reported results violently with the share price. Q1 2026's entire "profit" was a $14.3m derivative mark. Read reported net income with extreme skepticism — it is a share-price derivative, not performance.
3. A genuine impairment already taken: the Ascend Elements investment written to $nil (Q1 2026) on "significant uncertainty regarding recovery" — a real, booked loss and a cautionary read-through on battery-adjacency bets.
4. Financing complexity / dilution overhang: convertible notes (conv. $3.78), LAC + JV warrants, DOE put/call/exchange, PPA royalty, ATM programs — a dense stack of instruments that all dilute or encumber common equity. The PPA + MF2/Alnitak 8.0%→1.75% buy-down royalty ($22m to buy down; ~$422/t thereafter) are perpetual claims on revenue that are excluded from the technical-report economics — so the reported NPV modestly overstates the value accruing to common holders.
5. Going-concern: no formal going-concern doubt. Management asserts sufficient liquidity "for at least the next 12 months". But the "beyond 12 months" language is explicitly conditional on financings completing — a soft flag, not a red one.

Regulatory findings (required):

• SEC: No SEC Litigation Releases and no AAERs naming Lithium Americas, verified via EDGAR EFTS (LR + AAER) for 2021-07-06 → 2026-07-06.
• 10-K Item 3 (Legal Proceedings): "The Company has resolved or secured judicial dismissal of all legal and regulatory actions... There are no current adversarial matters involving the Company or its regulatory authorizations." The historically material tribal/environmental litigation (Reno-Sparks Indian Colony, Burns Paiute, Summit Lake Paiute) was dismissed (2023, not appealed) and the water-rights protest settled 30 Jul 2025. Mine Safety (Item 4): zero MSHA violations/citations/fatalities FY2025.
• Non-SEC web search: no material FTC/DOJ/FDA/CFPB enforcement, consent decree, fine, or penalty surfaced against Lithium Americas Corp.. The only "enforcement-adjacent" history is the now-resolved NEPA/permitting and water-rights litigation.
• Conclusion: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K Item 3 as of 2026-07-06.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

Honest re-point (per SKILL Lens-11 discipline for a pre-revenue builder): an EPS-for-3-fiscal-years model would be a fabrication — LAC earns ~$0 revenue through FY2027 and negative EPS until Phase 1 ramps in 2028. The correct projection is path-to-first-cash + a scenario on Phase-1 steady-state economics. No forecast.ts forecast is logged (unattended --watchlist rule; and no genuine EPS base case exists to commit).

Path (bottom-up from filed actuals + guidance):

• FY2026: revenue $0; capex $1.3–1.6bn (guided); operating burn ~$45–70m G&A/transaction; funded by remaining cash ($1.21bn) + 4 more quarterly DOE draws ($1.1bn undrawn) + ATM. Overhang: H2 2026 "definitive capital estimate" likely raises the $2.93bn number (tariffs $80–120m + inflation explicitly outside the estimate).
• FY2027: revenue ~$0 (mechanical completion late 2027; first product at year-end at best); pre-commissioning + commissioning spend; likely needs incremental capital if the capex revision is material.
• FY2028: first commercial revenue + ramp. Phase-1 steady state (LAC 62%, but 59% post-DOE-warrant, less PPA/royalty):

Phase-1 steady-state scenario (40kt/y, before Phases 2–5) — every input labeled:

• Volume: 40,000 t/y Li₂CO₃ (nameplate; design ~42,196 t/y).
• Opex: ~$8,039/t LOM avg (or ~$6,238/t Yrs 1–25). Use ~$6,300/t for early years.
• Bear price $12,000/t → EBITDA/t ≈ $5,700 → ~$228m project EBITDA × 62% = ~$141m to LAC.
• Base price $18,000/t → EBITDA/t ≈ $11,700 → ~$468m × 62% = ~$290m to LAC.
• Bull price $24,000/t (company assumption) → EBITDA/t ≈ $17,700 → ~$708m × 62% = ~$439m to LAC.
• Subtract DOE interest (Treasury-flat on $1.97bn ≈ $90–100m/yr once fully drawn ), Orion PPA/royalty ($422/t + 0.96% of revenue ), and cash taxes → LAC-attributable free cash from Phase 1 alone is modest at bear prices and material only at $18k+/t.

Punchline: Phase 1 alone, at conservative prices, roughly services the capital stack; the equity upside is levered to (a) lithium price >$18k/t and (b) Phases 2–5 (the path to 160kt/y and the $8.7bn Base-Case NPV). This is a 2028-and-beyond, price-levered, optionality story — not a near-term earnings compounder. Base call (not logged as a Brier forecast): first commercial Li₂CO₃ shipment slips to 2028; FY2026–27 EPS remain negative; a capex revision above $2.93bn is more likely than not.

Lens 12 · Bull vs Bear

Bull case. The US decided lithium is a national-security asset, and LAC is the one permitted, at-scale, domestic deposit that got the golden ticket: $2.23bn of below-market DOE debt, a GM anchor, and a 5% government equity backstop. Thacker Pass is fully funded to mechanical completion, 39% built, engineering essentially done. The 45X critical-minerals production credit survives the 2025 OBBBA phase-outs (it was kept for critical minerals even as wind/solar credits sunset) — a durable domestic-producer subsidy. If the clay flowsheet works, LAC owns 62% of an 85-year, 160kt/y machine with a company-modeled $8.7bn Base-Case NPV, in a market Fastmarkets/Benchmark expect to swing into structural deficit as ESS + EV demand outrun supply. Lithium already showed its teeth with a 95% price spike into early 2026. At ~1.5x book and a market cap that discounts the company's own NPV heavily, the risk/reward is a cheap call option on "first US lithium at scale + a lithium price recovery."

Bear case (2–3 permanent-impairment risks).

1. The flowsheet doesn't scale. Clay-hosted lithium via acid leach "has never been done at commercial scale." If recoveries, reagent consumption, or throughput miss at ramp, opex blows past $8k/t and the NPV inverts — a permanent impairment, not a timing issue. This is the existential risk and it is un-hedgeable until 2028.
2. Capex creep + dilution spiral. The $2.93bn estimate is already under revision upward (tariffs $80–120m + inflation explicitly excluded); Phase 1 crept from $2.27bn → $2.93bn once already. Every overrun is funded by more ATM dilution — the count already grew ~60% in a year. A bad "definitive estimate" in H2 2026 could force a large raise at a depressed price, permanently impairing per-share value even if the project succeeds.
3. Lithium price stays in the $10–14k/t doldrums. The bear NAV (~$510m at $9.5k/t, 15% discount ) is a real scenario if 2026–28 oversupply (new Argentine/Australian tonnes) materializes as Wood Mackenzie/Adamas warn. At those prices Phase 1 barely covers its capital and Phases 2–5 never get built — the optionality expires worthless.

Pre-mortem (18 months out, thesis broke): the H2 2026 definitive capex estimate came in at ~$3.5–3.8bn; LAC did a dilutive raise at ~$4; commissioning revealed lower-than-modeled clay recoveries; lithium sat at $11k/t on Argentine oversupply; the stock is a third lower and the Phase 2 decision is indefinitely deferred.

Are multiples too high? Wrong question — there are no multiples. The right question is whether the NPV assumptions ($24k/t, 8% discount) are too generous. They are optimistic relative to today's ~$12–15k/t reality; a fair blended view sits between the company case and the bear case.

Contrarian view (what the market refuses to see): the market treats LAC as a lithium-price bet, but the DOE loan (Treasury-flat, 23-yr, no principal to 2029) makes it far more a subsidized-infrastructure bet — the true asymmetry is that a US government + GM will do a lot to keep the first domestic lithium mine from failing, and that political put is underpriced relative to the flowsheet fear.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• Revenue concentration is total and forward: 100% of value depends on one asset, sold substantially to one customer (GM), using one unproven process. Any of the three cracking impairs the whole company. GM already extracted offtake priority + a profit true-up — it holds the leverage, not LAC.
• The moat is mostly other people's money. Strip out the DOE loan and GM, and LAC is a junior with a hard-to-process clay deposit and negative cash flow. The "moat" is a financing package, and financing packages come with DOE/GM control rights that subordinate common holders (put/call/exchange, board observer, asset-transfer restrictions preventing cash from leaving LN).
• Most dangerous competitor bulls underestimate: not another US clay miner — it's cheap South American brine + Australian spodumene coming back online. If SQM/Pilbara/Argentine DLE tonnes flood 2026–28, the marginal price sits below Thacker Pass's ~$8k/t all-in early opex advantage claim, and a permitted-but-high-cost US mine loses on economics even while winning on politics.
• Worst capital-allocation move: serial ATM dilution at $3.71–$8.19 — ~60% more shares in a year, much of it below the eventual break-even needed to justify the build. The convertible + warrant + PPA + royalty stack are all further claims ahead of common equity.
• What must hold for ~$4.84: lithium recovers to ~$15–18k/t by ramp; capex doesn't blow materially past $2.93bn; the flowsheet hits nameplate recovery; no additional massively-dilutive raise. That's four things that all have to go right, on a first-of-its-kind process.
• If growth disappoints 20–30% (lower recovery / lower price): the NPV moves from $8.7bn toward the bear's ~$0.5bn band — i.e. the equity could be worth a fraction of today, because value is a leveraged residual after a fixed ~$3bn+ capital stack.
• Single permanent-impairment scenario, plausibility: clay-leach ramp fails to hit recovery/throughput → asset impairment + forced restructuring of the capital stack. Plausibility: moderate — Bechtel/Aquatech/MECS are top-tier and the pilot plant has made battery-grade product since 2022, which lowers (but does not eliminate) the risk.

Lens 14 · Management Questions (ordered by information value)

1. What is the H2 2026 definitive capital estimate likely to show versus $2.93bn, and what tariff/inflation/logistics contingency is now embedded?
2. At what lithium-carbonate price does Phase 1 generate positive LAC-attributable free cash flow after DOE debt service, PPA, and royalty?
3. What are the actual demonstrated recovery rates and reagent-consumption figures from the integrated pilot plant, and how do they compare to the 82.1% (Yrs 1–25) LOM design recovery at commercial scale?
4. How will the remaining ~$1.1bn of undrawn DOE principal + any capex overrun be funded without further large equity dilution — and what is the ceiling on additional ATM issuance?
5. Under what conditions does the DOE exercise its warrants, and what is the fully-diluted share count / JV-economic dilution in that scenario?
6. What is the realistic Phase 2 FID timeline, and does it depend on Phase 1 hitting nameplate and a specific lithium price?
7. What binding third-party offtake (beyond GM's 20%-of-needs floor) has been secured for uncommitted Phase 1 volumes, and at what pricing structure?
8. What are the reagent supply contracts (soda ash, liquid sulfur) — locked, indexed, or spot — and what is the opex sensitivity if they aren't secured at model prices?
9. How exposed is the completion schedule to the UAE steel / Strait of Hormuz logistics chain, and what is the contingency if the Port of Jeddah re-route is disrupted?
10. What is the impairment trigger on the $1.67bn Thacker Pass carrying value — at what lithium price / recovery does the DCF test fail?
11. What are GM's rights if LAC misses construction milestones, and can GM's offtake priority + profit true-up materially reduce LAC's realized price?
12. What is the plan to replace the DOE reserve accounts / GM LC facility with project cash, and what construction milestones unlock cash transfers out of LN?
13. How should investors think about capitalized interest flattering the balance sheet — what is the true all-in cost of the Thacker Pass asset including financing?
14. What is management's read on structural lithium supply/demand into 2028–30, and how much of the thesis needs price recovery vs. cost leadership?
15. Beyond Thacker Pass, is there any capital-allocation intent (M&A, the GT1/Ascend-type minority stakes) or is LAC a single-asset pure-play indefinitely?

---